Recombinant CD47 (Magrolimab Biosimilar) antibody
-
- Target See all CD47 (Magrolimab Biosimilar) products
- CD47 (Magrolimab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonality
- Monoclonal
-
Conjugate
- This CD47 (Magrolimab Biosimilar) antibody is un-conjugated
-
Application
- ELISA
- Purpose
- Magrolimab Biosimilar - Anti-CD47 mAb
- Characteristics
- Antibody Type: IgG4-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Grade
- Research Grade
- Isotype
- IgG4 kappa
-
anti-CD47 (Magrolimab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Mouse Chimeric unconjugated Recombinant Antibody
anti-CD47 (Magrolimab Biosimilar) antibodyResearch Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- CD47 (Magrolimab Biosimilar)
- Abstract
- CD47 (Magrolimab Biosimilar) Products
- Target Type
- Biosimilar
- Background
-
Hu5F9-G4
Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity. - CAS-No
- 2169232-81-7
-
